Telix Pharmaceuticals Limited (TLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Company Overview - Telix is a globally active, pure-play radiopharmaceutical company with a commercial stage focus [2] - The company operates in 26 countries, indicating a broad international presence [2] Value Creation Strategy - Telix has three pillars of value creation, focusing on a portfolio of products targeting cancers and rare diseases [3] - The company develops both imaging agents and therapeutics, emphasizing a precision medicine strategy [3]